Condition
Antineoplastic Agents clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Antineoplastic Agents clinical trials that are recruiting, at sites in 3 countries (most in China (4), Spain (1), Italy (1)). By phase: Phase 2 (2), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 3Countries
Newest Antineoplastic Agents clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Fecal transplant for chemotherapy and targeted-therapy gut side effects in advanced gastrointestinal cancer | Phase 1 | Zhejiang, Hangzhou | Recruiting | Jan 6, 2026 |
| Combining Befotertinib with Bevacizumab or Chemotherapy for Lung Cancer Treatment | Phase 2 | Shanghai, Shanghai Municipality | Recruiting | Jan 1, 2025 |
| Using vorolanib for treating advanced kidney cancer | — | Nanjing, Jiangsu | Recruiting | Nov 6, 2024 |
| Single versus dual antiplatelet therapy after drug-coated balloon angioplasty in elderly or high-bleeding-risk patients | — | Milan, MI | Recruiting | Aug 2, 2024 |
| Nivolumab with chemotherapy for treating primary tracheal squamous cell carcinoma | Phase 2 | Guangzhou, Guangdong | Recruiting | Jul 27, 2023 |
| Preventing heart issues in elderly cancer patients | — | Santiago de Compostela, A Coruña and 13 other locations | Recruiting | Oct 18, 2018 |
All recruiting trials (6)
-
Fecal transplant for chemotherapy and targeted-therapy gut side effects in advanced gastrointestinal cancer
This trial will try oral fecal microbiota transplants (FMT) to see if they reduce chemotherapy or targeted-therapy–related gut symptoms in adults with advanced gastrointestinal cancers.
-
Combining Befotertinib with Bevacizumab or Chemotherapy for Lung Cancer Treatment
This study is testing if a new lung cancer treatment combining befotertinib with either bevacizumab or chemotherapy can help patients with early-stage cancer that has an EGFR mutation feel better before surgery.
-
Using vorolanib for treating advanced kidney cancer
This study is testing if the drug vorolanib can help people with advanced kidney cancer live longer when used as a second treatment option.
-
Single versus dual antiplatelet therapy after drug-coated balloon angioplasty in elderly or high-bleeding-risk patients
This study tests whether taking one antiplatelet medicine is as safe and causes less bleeding than taking two medicines for people aged 75 or older, or adults at high bleeding risk, after drug-coated balloon angioplasty for coronary artery disease.
-
Nivolumab with chemotherapy for treating primary tracheal squamous cell carcinoma
This study is testing whether combining a new immune therapy called Nivolumab with chemotherapy can help people with a rare type of throat cancer before surgery.
-
Preventing heart issues in elderly cancer patients
This study is testing whether close heart monitoring and teamwork among doctors can help older cancer patients avoid heart problems and live longer compared to standard care.
Related topics
Quick answers
How many Antineoplastic Agents clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in China (4 trials), Spain (1 trial), Italy (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.